MedTrace Logo

Comparison of Decolonization of Methicillin-resistant Staphylococcus Aureus (MRSA) Using Theraworx

NCT00713674 · Status: WITHDRAWN · Phase: NA · Type: INTERVENTIONAL

Last updated 2017-03-23

No results posted yet for this study

Summary

The purpose of this study is to examine treatment method of Methicillin-resistant Staphylococcus aureus (MRSA) decolonization in patients.

Conditions

  • Methicillin-Resistant Staphylococcus Aureus

Interventions

OTHER

Theraworx

Theraworx swab intranasal BID for 5 days

DRUG

mupirocin antibiotic ointment

mupirocin antibiotic ointment swab intranasal BID for 5 days

Sponsors & Collaborators

  • Mercy Research

    lead OTHER

Principal Investigators

  • Roger E Huckfeldt, MD · Mercy/St. John's Hospital - Springfield

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
SINGLE
Model
PARALLEL

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2008-03-31
Primary Completion
2009-02-28
Completion
2009-02-28

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT00713674 on ClinicalTrials.gov